![The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women - ScienceDirect The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825820300676-gr1.jpg)
The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women - ScienceDirect
![Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)? - ScienceDirect Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825813003065-gr1.jpg)
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)? - ScienceDirect
![Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study - ScienceDirect Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0301211518303452-gr1.jpg)
Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study - ScienceDirect
![Flowchart study population. HPV, human papillomavirus; CIN, cervical... | Download Scientific Diagram Flowchart study population. HPV, human papillomavirus; CIN, cervical... | Download Scientific Diagram](https://www.researchgate.net/profile/Nelly-Mugo/publication/267744432/figure/fig1/AS:295691407642633@1447509733730/Flowchart-study-population-HPV-human-papillomavirus-CIN-cervical-intraepithelial.png)
Flowchart study population. HPV, human papillomavirus; CIN, cervical... | Download Scientific Diagram
![This figure describes management of histologic LSIL (CIN 1) preceded by... | Download Scientific Diagram This figure describes management of histologic LSIL (CIN 1) preceded by... | Download Scientific Diagram](https://www.researchgate.net/publication/340379784/figure/fig4/AS:884611643092992@1587919259191/This-figure-describes-management-of-histologic-LSIL-CIN-1-preceded-by-HSIL-cytology.png)
This figure describes management of histologic LSIL (CIN 1) preceded by... | Download Scientific Diagram
![Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. - Abstract - Europe PMC Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3616418/bin/nihms440304f1.jpg)
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. - Abstract - Europe PMC
![Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2—a prospective clinical multicenter cohort study - American Journal of Obstetrics & Gynecology Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2—a prospective clinical multicenter cohort study - American Journal of Obstetrics & Gynecology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a61a2460-3157-4d28-b675-ddc11d3c7d5c/gr1_lrg.jpg)
Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2—a prospective clinical multicenter cohort study - American Journal of Obstetrics & Gynecology
![Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women - Cervical Outcomes Similar With Immediate Cryotherapy and Standard Cytology in HIV+ Women Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women - Cervical Outcomes Similar With Immediate Cryotherapy and Standard Cytology in HIV+ Women](https://www.natap.org/2018/images%20/032318/032318-6/0323183.gif)
Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women - Cervical Outcomes Similar With Immediate Cryotherapy and Standard Cytology in HIV+ Women
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
![The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions | Nature Communications The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-020-15856-y/MediaObjects/41467_2020_15856_Fig1_HTML.png)